%0 Journal Article
%A Kayser, Sabine
%A Krzykalla, J.
%A Elliott, M. A.
%A Norsworthy, K.
%A Gonzales, P.
%A Hills, R. K.
%A Baer, M. R.
%A Ráčil, Z.
%A Mayer, J.
%A Novak, J.
%A Žák, P.
%A Szotkowski, T.
%A Grimwade, D.
%A Russell, N. H.
%A Walter, R. B.
%A Estey, E. H.
%A Westermann, J.
%A Görner, M.
%A Benner, A.
%A Krämer, A.
%A Smith, B. D.
%A Burnett, A. K.
%A Thiede, C.
%A Röllig, C.
%A Ho, A. D.
%A Ehninger, G.
%A Schlenk, Richard
%A Tallman, M. S.
%A Levis, M. J.
%A Platzbecker, U.
%T Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.
%J Leukemia
%V 31
%N 11
%@ 1476-5551
%C Basingstoke
%I Nature Publ. Group
%M DKFZ-2017-05883
%P 2347 - 2354
%D 2017
%X Therapy-related acute promyelocytic leukemia (t-APL) is relatively rare, with limited data on outcome after treatment with arsenic trioxide (ATO) compared to standard intensive chemotherapy (CTX). We evaluated 103 adult t-APL patients undergoing treatment with all-trans retinoic acid (ATRA) alone (n=7) or in combination with ATO (n=24), CTX (n=53), or both (n=19). Complete remissions were achieved after induction therapy in 57
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:28322237
%R 10.1038/leu.2017.92
%U https://inrepo02.dkfz.de/record/130805